Basel Medical Plunges 12.5% on Bitcoin Acquisition Pause

On July 18, 2025, Basel Medical's stock price plummeted by 12.5% in pre-market trading, marking a significant downturn for the company.

Basel Medical Group has decided to pause its acquisition of Bitcoin (BTC) digital assets following extensive discussions with a consortium of BTC holders. This decision comes amid ongoing regulatory reviews and uncertainty in the US, which has led to a halt in the acquisition process. The company maintains flexibility to reassess the deal in the future.

In addition to the paused acquisition, Basel Medical Group has also obtained a waiver of lock-up for potential strategic fund raising. This move allows the company to explore new funding opportunities and strengthen its financial position amid market volatility. The company has reaffirmed its strong financial position, which may help mitigate the impact of the paused acquisition on its stock price.

Furthermore, Basel Medical Group's subsidiary has been awarded a S$375 million contract to supply healthcare products. This contract will enhance the group's AI-powered healthcare supply chain capabilities, potentially driving future growth and innovation in the healthcare sector.